SAP has made a strategic investment in Munich-based HealthTech company Avelios Medical, whilst launching a share buyback programme worth up to €10 billion to restore investor confidence following significant share price losses. The investment is linked to SAP's withdrawal from the traditional hospital information systems market by 2030. SAP's shares have fallen approximately 37% from their June 2025 peak, trading at €170.32, with a 15% decline since the start of 2026. The drop followed disappointing cloud order backlog figures in Q4 2025, despite solid overall performance including 26% cloud revenue growth and free cash flow exceeding €8 billion. The company is implementing countermeasures, including the buyback programme running until end-2027, a proposed €2.50 dividend per share, and focusing on AI integration, with two-thirds of Q4 cloud orders containing AI components.

SAP invests in Avelios Medical. News article. SAP, one of our long-standing limited partners, makes a strategic investment in our portfolio company Avelios Medical, a company that is reshaping hospital IT and clinical workflows. Together, Avelios and SAP offer an open, AI-native and sovereign platform, developed in Europe and designed for enterprise-scale hospital rollouts. SAP's commitment reflects conviction in a company that HTGF has backed at the earliest stage. At HTGF, we sit at the intersection of bold founders and industry-defining LPs. When the two sides connect that's the HTGF flywheel working. What makes Avelios particularly compelling is its timing. The IS-H transformation is reshaping the clinical IT market, and hospitals facing fundamental IT realignments need orientation. Avelios is exactly that. The company offers a platform that integrates clinical workflows, patient data, and administrative processes - built on a structured, semantically consistent data model that enables interoperability and clinical intelligence at enterprise scale. Daniela bach principal. I am your contact. More news. 26 February 2026 Europe builds again as fusion moves from lab to grid: proxima fusion on its way to strengthening european energy sovereignty. Clee Medical secures seed financing to advance real-time brain imaging for neurosurgery. 25 February 2026 17 February 2026 Growth turbo for the heating transition: nuuenergy raises €4.3 million to revolutionise the heat-pump market with craft expertise. 11 February 2026 INLEAP photonics secures pre-seed funding to develop laser-based counter-drone system for defence and critical infrastructure. 2 February 2026

Avelios Medical, a provider of AI-native hospital information systems, has received a strategic investment from SAP to jointly develop the healthcare platform of the future. The investment comes as hospitals navigate the IS-H transformation in the clinical information systems market. The partnership combines Avelios's clinical process expertise with SAP's enterprise integration capabilities to create an open, AI-native platform developed in Europe. Avelios will use the funding to scale team capacity, focusing on product development and delivery structures for enterprise-scale rollouts. The solution features a cloud-native, modular architecture with structured data models enabling AI automation and intelligent orchestration of clinical and operational processes. SAP's investment provides access to its global ecosystem of implementation partners and decades of enterprise transformation expertise, offering hospitals investment security during fundamental IT realignments.